Fennec Pharmaceuticals Inc. (FENC) Profit Margin
Fennec Pharmaceuticals Inc. (FENC) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2022-12-31 | -1544.89% |
| 2023-12-31 | -75.55% |
| 2024-12-31 | -0.92% |
| 2025-12-31 | -21.82% |
How FENC compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| HAE | Haemonetics Corporation | 7.29% |
| NVST | Envista Holdings Corporation | 1.73% |
| VREX | Varex Imaging Corporation | -8.32% |
| PRGO | Perrigo Company plc | -33.51% |
| TFX | Teleflex Incorporated | -45.45% |
These are five companies in the same sector as FENC with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Fennec Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("FENC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FENC | $12.39 | -1.27% | 0.21M |
| 3 | ||||
| 4 | ||||
| 5 |